Letter to the Editor Regarding “The Challenges of Switching Therapies in an Evolving Multiple Biosimilars Landscape: A Narrative Review of Current Evidence”

Detalles Bibliográficos
Autores principales: Finck, Barbara, Geller, Robert B., Walden, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189954/
https://www.ncbi.nlm.nih.gov/pubmed/33914268
http://dx.doi.org/10.1007/s12325-021-01694-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189954/
https://www.ncbi.nlm.nih.gov/pubmed/33914268
http://dx.doi.org/10.1007/s12325-021-01694-x

Ejemplares similares